Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Fluoxetine Sandoz CMI 20 Jan 2017
Boostrix Preservative-free CMI 20 Jan 2017
Boostrix Preservative Free PI 20 Jan 2017
Rapamune Tablets CMI 20 Jan 2017
Jardiance PI 20 Jan 2017

New products

Product name Type Date released
Olmesarta/HCT Sandoz CMI 20 Jan 2017
Olmesartan/HCT Sandoz PI 20 Jan 2017
Calcipotriol/Betamethasone Sandoz 50/500 CMI 20 Jan 2017
Calcipotriol/Betamathasone Sandoz 50/500 PI 20 Jan 2017
Folotyn CMI 18 Jan 2017